Biogen Corp (BIIB) Company Long-Term Loans and Borrowings

Symbol and logo of brand Biogen Corp (BIIB)

Biogen Inc. monetizes unique drugs for rare pathologies through premium pricing, while the firm's long-term debt capital on GURU.Markets brings 7.01, which represents the latest metric reading. The development of neuropharmaceuticals relies on global alliances and the acquisition of startups. The search for new therapies is accelerating through the implementation of robotic molecular bioscreening in laboratories.

BIIB biogen.com: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Financial and market metric breakdowns for Biogen Corp (BIIB)

- price and consensus price forecast:
Stock Price biogen.com|BIIB - Price Target Chart
- market capitalization data:
Market Value Biogen|BIIB - Total Company Value
- book capitalization data:
Net Asset Value per Share Biogen|BIIB - Book Capitalization|Market Value to Book Value Ratio biogen.com|BIIB - Company Total Assets
- debt and liquidity data:
Total Debt to Capital Coefficient Biogen Inc.|BIIB - Long-Term Debt to Equity|Current Liabilities to Capital Biogen Idec|BIIB - Company Aggregate Debts|Debt to Net Assets Biogen|BIIB - Company Long-Term Debts|Short-Term Debt Biogen
Summary company analysis:BIIB (biogen.com)
Manufactured products of Biogen

This metric aggregates the total credit obligations and bonds of Biogen Inc. (BIIB) with maturities exceeding twelve months. Monitoring this metric allows investors to promptly detect a critical increase in debt load that could threaten financial stability. By analyzing the time series of the firm's long-term borrowings, one can assess the cost of capital, which is particularly vital for financing in-house drug substance production while simultaneously outsourcing clinical trials.

Direct competitors

neurocrine.com - Company Long-Term Debts|Company Long-Term Debt Regencell Bioscience Holdings Limited (RGC)|AXSM: Company Long-Term Loans and Borrowings|Company Long-Term Debt ACAD|Xenon Corp (XENE) - Long-Term Debt|Company Long-Term Debts Viking Therapeutics|Company Long-Term Debt supernus.com|CPRX (Catalyst Pharmaceuticals, Inc.) - Company Long-Term Debts|Long-Term Debt Volume DNLI (Denali)|HRMY: Company Long-Term Debt|Long-Term Debt Biohaven Corp BHVN|Company Long-Term Debts AMLX|TRVI - Long-Term Indebtedness|Company Long-Term Debts PRAX|AVXL (Anavex) - Long-Term Debt|Company Long-Term Debt CeriBell Corp (CBLL)|Company Long-Term Indebtedness prothena.com (PRTA)|Alector, Inc. (ALEC) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings annexonbio.com (ANNX)|Company Long-Term Debts OMER|Neurogene Inc - Long-Term Debt Volume|AC Immune Corp (ACIU) - Company Long-Term Debt|VYGR - Company Long-Term Indebtedness|NMRA (Neumora Therapeutics) - Company Long-Term Debts|Company Long-Term Liabilities scilexholding.com|TVGN: Company Long-Term Liabilities|Long-Term Debt Volume Alpha Cognition Corp|Company Long-Term Debts Cognition Therapeutics (CGTX)|Company Long-Term Debt Inhibikase Pharma (IKT)|Company Long-Term Debts SAVA|Long-Term Debt Volume Assertio Holdings ASRT|Company Long-Term Debts COYA (Coya)|VTGN - Long-Term Debt Volume|ovidrx.com (OVID) - Company Long-Term Debts|ABOS (Acumen Pharmaceuticals, Inc) - Company Long-Term Debt|Company Long-Term Debt CervoMed Inc. (CRVO)|Company Long-Term Indebtedness Alterity Therapeutics Ltd|Clene Inc. - Company Long-Term Debts|Long-Term Debt pepgen.com PEPG|Company Long-Term Liabilities JUNS (Jupiter Neurosciences Inc)|Relmada Corp - Company Long-Term Debts|Company Long-Term Debt Annovis Bio, Inc. (ANVS)|GRCE: Company Long-Term Loans and Borrowings|Company Long-Term Debt AIFF|Klotho Neurosciences (KLTO) - Long-Term Debt|Company Long-Term Debts NeuroSense Therapeutics Ltd|Company Long-Term Debt Reviva Pharmaceuticals, Inc.|MTVA (MetaVia Inc) - Company Long-Term Debts|Long-Term Debt Volume NRXS (neuraxis.com)|HSDT: Company Long-Term Debt|Long-Term Debt Passage Bio Inc. PASG|Company Long-Term Debts NEUP|NERV - Long-Term Indebtedness|Company Long-Term Debts ATHA|ADXN (addextherapeutics.com) - Long-Term Debt|Company Long-Term Debt Alzamend Neuro Inc. (ALZN)|Company Long-Term Indebtedness Cyclerion (CYCN)|Protagenic Therapeutics (PTIX) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings pasitheaclinics.com (KTTA)|Company Long-Term Debts CRGT|avenuetx.com - Long-Term Debt Volume|BrainStorm Cell Therapeutics (BCLI) - Company Long-Term Debt|CARA - Company Long-Term Indebtedness|CHRO (Chromocell Therapeutics Corporation) - Company Long-Term Debts|Company Long-Term Liabilities Eliem Therapeutics Inc.|ITCI: Company Long-Term Liabilities|Long-Term Debt Volume longboardpharma.com|Company Long-Term Debts Marinus Pharmaceuticals, Inc. (MRNS)|Company Long-Term Debt NKGen Biotech Inc (NKGN)|Company Long-Term Debts NRBO|Long-Term Debt Volume Sage Therapeutics Inc SAGE|Company Long-Term Debts SNPX (Synaptogenix, Inc.)|TRVN - Long-Term Debt Volume|vigilneuro.com (VIGL) - Company Long-Term Debts|WENA (Anew Medical Inc.) - Company Long-Term Debt|Company Long-Term Debt Cerevel (CERE)